Afonso, G
While this article has focused on the differing requirements for people using GLP-1s for weight loss, the list of proposed indications for GLP-1s grows seemingly on a daily basis, with research currently ongoing in neurodegenerative disease, chronic kidney disease and liver disease
Generic market entry On 21 March, Dr Reddys, Sun Pharma, Zydus Lifesciences, Glenmark, Alkem, and Natco launched generic semaglutide formulations
Avoid taking a dose of Vyvanse in the afternoon
Instead, it is localized to intestinal subepithelial myofibroblasts and enteroendocrine cells
Conversely, some patients opt for evening or nighttime administration, particularly if they experience gastrointestinal side effects such as nausea